I agree that this site is using cookies. You can find further informations here.
X
KARABUDAK, RANA
230  results:
Search for persons X
?
1

Navigating the discontinuation of multiple sclerosis first ..:

Ozen, Nazire Pinar Acar ; Dursun, Ece Gok ; Tuncer, Asli.
Multiple Sclerosis and Related Disorders.  84 (2024)  - p. 105503 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Impact of COVID-19 on pregnancy and fetal outcomes in women..:

Aprea, Maria Grazia ; Schiavetti, Irene ; Portaccio, Emilio...
Multiple Sclerosis Journal.  30 (2024)  6 - p. 707-713 , 2024
Link: https://doi.org/10.1177/..
 
?
3

Faible activité de la maladie après un traitement de 4 ans ..:

Brochet, Bruno ; Patti, Francesco ; Bermel, Robert...
Revue Neurologique.  180 (2024)  - p. S146-S147 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Prevalence and incidence of multiple sclerosis in Turkey: A..:

Öztürk, Bilgin ; Taşkıran, Esra ; Demir, Serkan...
Multiple Sclerosis Journal.  30 (2024)  7 - p. 790-799 , 2024
Link: https://doi.org/10.1177/..
 
?
5

ENSEMBLE PLUS: final results of shorter ocrelizumab infusio..:

Hartung, Hans-Peter ; Berger, Thomas ; Bermel, Robert A....
Journal of Neurology.  271 (2024)  7 - p. 4348-4360 , 2024
Link: https://doi.org/10.1007/..
 
?
6

Comparative Effectiveness of Natalizumab, Fingolimod, and I..:

Spelman, Tim ; Simoneau, Gabrielle ; Hyde, Robert...
Neurology.  102 (2024)  7 - p. , 2024
Link: https://doi.org/10.1212/..
 
?
7

The comparative effectiveness of fingolimod, natalizumab, a..:

Boz, Cavit ; Ozakbas, Serkan ; Terzi, Murat...
Neurological Sciences.  44 (2023)  6 - p. 2121-2129 , 2023
Link: https://doi.org/10.1007/..
 
?
8

The risk of secondary progressive multiple sclerosis is geo..:

Sharmin, Sifat ; Roos, Izanne ; Simpson-Yap, Steve...
Brain.  146 (2023)  11 - p. 4633-4644 , 2023
Link: https://doi.org/10.1093/..
 
?
9

Impact of COVID-19 vaccination or infection on disease acti..:

Cohen, Mikael ; Thomel-Rocchi, Océane ; Siva, Aksel...
Multiple Sclerosis Journal.  29 (2023)  9 - p. 1099-1106 , 2023
Link: https://doi.org/10.1177/..
 
?
10

Low Disease Activity Over 4 Years of Ocrelizumab Therapy in..:

Bermel, Robert ; Hartung, Hans-Peter ; Brochet, Bruno...
Neurology.  100 (2023)  17_supplement_2 - p. , 2023
Link: https://doi.org/10.1212/..
 
?
11

mRNA versus inactivated virus COVID-19 vaccines in multiple..:

Tütüncü, Melih ; Demir, Serkan ; Arslan, Gökhan...
Multiple Sclerosis and Related Disorders.  75 (2023)  - p. 104761 , 2023
Link: https://doi.org/10.1016/..
 
?
12

Infusion-Related Reactions With Ocrelizumab: Risk Factors, ..:

Bermel, Robert ; Killestein, Joep ; Berger, Thomas...
Neurology.  100 (2023)  17_supplement_2 - p. , 2023
Link: https://doi.org/10.1212/..
 
?
13

Predictors of treatment switching in the Big Multiple Scler..:

Spelman, Tim ; Magyari, Melinda ; Butzkueven, Helmut...
Frontiers in Neurology.  14 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
14

Sars-CoV2 infection in pregnant women with multiple scleros..:

Aprea, Maria Grazia ; Schiavetti, Irene ; Portaccio, Emilio...
Multiple Sclerosis Journal.  29 (2023)  9 - p. 1090-1098 , 2023
Link: https://doi.org/10.1177/..
 
?
15

The Role of C3 and C4 Complement Levels in the Differential..:

Çakan, Melike ; Çimen, Barışcan ; Ozen, Nazire Acar..
Neurology.  100 (2023)  17_supplement_2 - p. , 2023
Link: https://doi.org/10.1212/..
 
1-15